Friess Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-105,675
Closed -$8.34M 103
2020
Q1
$8.34M Sell
105,675
-163,131
-61% -$13.6M 0.83% 49
2019
Q4
$23.3M Hold
268,806
1.63% 17
2019
Q3
$22.5M Hold
268,806
1.74% 14
2019
Q2
$22.6M Hold
268,806
1.65% 15
2019
Q1
$21.5M Sell
268,806
-194
-0.1% -$14.4K 1.58% 14
2018
Q4
$19.5M Hold
269,000
1.66% 14
2018
Q3
$19.7M Hold
269,000
1.38% 35
2018
Q2
$16.4M Hold
269,000
1.3% 39
2018
Q1
$16.1M Buy
+269,000
New +$16.2M 1.32% 33
2016
Q3
Sell
-100,000
Closed -$3.93M 143
2016
Q2
$3.93M Buy
+100,000
New +$3.98M 0.4% 70
2015
Q3
Sell
-350,060
Closed -$17.2M 154
2015
Q2
$17.2M Buy
+350,060
New +$16.8M 1.44% 25

Other funds holding ABT

Friess Associates's ABT Position: Q2 2020 in Review

Friess Associates sold out of Abbott (ABT) in Q2 2020, closing a stake of 105,675 shares — an estimated $8.34M sold.

Friess Associates first reported a position in ABT in Q2 2015 and held it in 11 quarters. The position peaked at $23.3M in Q4 2019. 2,246 funds tracked by Wall St. Rank hold ABT as of Q2 2020.

  • Friess Associates reported no remaining Abbott position as of Q2 2020 after selling out during the quarter.
  • Friess Associates sold 105,675 Abbott shares in Q2 2020, an estimated $8.34M.
  • Friess Associates first reported a position in Abbott in Q2 2015 and held it in 11 quarters.
  • Friess Associates's Abbott position peaked at $23.3M in Q4 2019.
  • 2,246 funds tracked by Wall St. Rank held Abbott as of Q2 2020.

Based on Friess Associates's 13F filing for Q2 2020, filed 14 Aug 2020.